Latest Liquidity News

Yowie Group’s latest quarters reveal falling revenues and shrinking cash reserves, even as new leadership and product launches aim to stabilise the confectionery maker’s turnaround.

Orcoda Limited has lifted its Annual Recurring Revenue by 23% year-on-year to $6.2 million, with a new multi-year Wagner Corporation contract pushing total ARR to $14.2 million as it enters FY27.

Spenda Limited anticipates a significant R&D tax offset exceeding AUD 1.75 million for FY26, providing a timely cash boost amid its push towards cash-flow neutrality.

Mastermyne delivered FY26 revenue of $237.7 million and underlying EBITDA of $20.3 million, beating its own guidance amid robust strata consolidation activity. The company’s order book and near-term pipeline have expanded, while net cash rose to $46.5 million despite a pending legal penalty.

Beach Energy delivered a solid FY26 with 19.4 MMboe production, a record 18 months without injuries, and a key Otway Basin asset sale freeing $500 million capital.

Black Canyon's pilot scale Dense Media Separation testwork boosts manganese grades at Wandanya to 41% with recoveries around 80%, underpinning a promising development pathway.

Noxopharm reported significant progress in its Sofra technology, highlighting enhanced cancer drug potential and preparations for a US FDA clinical trial, while managing tight cash reserves.

Westgold Resources delivered a record 387,354oz gold production in FY26, exceeding guidance, while closing the year with a robust $939 million in cash and liquid assets, remaining debt free and unhedged.

Buru Energy pushes forward with its Rafael Gas Project development, securing A$5.3 million in funding and progressing environmental approvals while navigating executive leadership changes.

SkyCity Entertainment Group has signed a non-binding heads of agreement to sell The Grand Hotel, aiming to boost financial flexibility through asset monetisation and debt repayment.

Ceretas Limited is raising $8 million through an IPO to fund clinical trials and development of its novel therapeutic ultrasound device targeting Alzheimer’s disease symptoms.

XPON Technologies delivered a positive unaudited Group EBITDA of $1.1 million for FY26, supported by strategic divestments and a focus on its AI marketing platform Wondaris. The company improved gross margins and maintained strong customer retention despite divesting non-core businesses.